Bookedited by Xiaoyuan Chen, Stephen Wong.
Contents:
I: In vitro diagnostics. Cancer theranostics: an introduction
Genomics-based cancer theranostics
Proteomics-based theranostics
II: Molecular imaging. Radionuclide imaging of cancer therapy
Near-infrared fluorescence imaging probes for cancer diagnosis and treatment
Bioluminescence imaging of cancer therapy
Magnetic resonance imaging of cancer therapy
Ultrasound imaging of cancer therapy
Photoacoustic imaging for cancer diagnosis and therapy guidance
III: Imaging-guided therapy. Multimodality image-guided lung intervention systems
Label-free molecular vibrational imaging for cancer diagnosis
Multimodality image-guided treatment
Medical robotics for cellular and molecular imaging
IV: Theranostic platforms. Porphyrins for imaging, photodynamic therapy, and photothermal therapy
Magnetic resonance imaging and alternating magnetic fields
Ultrasound for drug/gene delivery
Radionuclides for imaging and therapy in oncology
Noble metal nanoparticle platform
Cancer theranostics with carbon-based nanoplatforms
Silica nanoparticle platform
Quantum dots for traceable therapeutic delivery
Polymer- and protein-based nanotechnologies for cancer theranostics
V: Other. Clinical translation and regulations of theranostics
Scale-up production of theranostic nanoparticles
Market considerations for nanomedicines and theranostic nanomedicines
Application of theranostics to measure and treat cell heterogeneity in cancer.